Progressing from Metformin to Sulfonylureas or Meglitinides

21Citations
Citations of this article
84Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The article provides an overview of sulfonylureas and meglitinides as second-line agents for treating type 2 diabetes mellitus (T2DM). Implications for occupational health clinicians who work with these individuals when they take either of these medications to achieve target glycemic indices are emphasized.

Cite

CITATION STYLE

APA

Grant, J. S., & Graven, L. J. (2016). Progressing from Metformin to Sulfonylureas or Meglitinides. Workplace Health and Safety, 64(9), 433–439. https://doi.org/10.1177/2165079916644263

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free